Cite
HARVARD Citation
Niemeyer, B. et al. (2022). Broad antiviral and anti‐inflammatory efficacy of nafamostat against SARS‐CoV‐2 and seasonal coronaviruses in primary human bronchiolar epithelia. Nano select. 3 (2), pp. 437-449. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Niemeyer, B. et al. (2022). Broad antiviral and anti‐inflammatory efficacy of nafamostat against SARS‐CoV‐2 and seasonal coronaviruses in primary human bronchiolar epithelia. Nano select. 3 (2), pp. 437-449. [Online].